Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Carmen González San Segundo"'
Autor:
Francisco Díaz Gutiérrez, Carmen González San Segundo, Paula Sedano Ferreras, Maitane Andión Catalán, David Ruano Domínguez
Publikováno v:
Anales de Pediatría, Vol 95, Iss 6, Pp 473-475 (2021)
Externí odkaz:
https://doaj.org/article/fe696ce50e1a437ba9f3a81899c6e667
Autor:
Francisco Díaz Gutiérrez, Carmen González San Segundo, Paula Sedano Ferreras, Maitane Andión Catalán, David Ruano Domínguez
Publikováno v:
Anales de Pediatría (English Edition), Vol 95, Iss 6, Pp 473-475 (2021)
Externí odkaz:
https://doaj.org/article/c2972d5645ce46b3893a1ab0c0ae63b5
Publikováno v:
Annals of Breast Surgery. 7:33-33
Autor:
Almudena Zapatero, Araceli Guerrero, Xavier Maldonado, Ana Álvarez, Carmen González San-Segundo, María Ángeles Cabeza Rodríguez, Josep María Solé, Agustí Pedro Olivé, Francesc Casas, Ana Boladeras, Carmen Martín de Vidales, María Luisa Vázquez de la Torre, Susana Vara, Juan Luis Sanz, Felipe A Calvo
Publikováno v:
The Lancet Oncology. 23:671-681
The optimal duration of androgen deprivation combined with high-dose radiotherapy in prostate cancer remains controversial. The DART 01/05 trial was designed to determine whether long-term androgen deprivation is superior to short-term androgen depri
Autor:
Xavier Maldonado, Carmen Martín de Vidales, Felipe A. Calvo, A. Guerrero, Almudena Zapatero, M.A. Cabeza, Ana Boladeras, Susana Vara, Ana Alvarez, Francesc Casas, Carmen González San Segundo, J.M. Solé, Agustí Pedro Olive, Maria Luisa Vazquez de la Torre
Publikováno v:
Radiotherapy and Oncology. 160:115-119
The optimal prognostic value of testosterone following androgen deprivation therapy (ADT) is controversial. We studied the effect of serum testosterone levels on clinical outcome in localized prostate cancer (PCa) treated with ADT and high-dose radio
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 39:351-356
In the management of prostate cancer , few treatments have caused as much controversy as adjuvant radiotherapy (ART) after radical prostatectomy in high-risk patients In the present article, we assess the exclusion and inclusion criteria of the 6 ran
Autor:
Maitane Andión Catalán, Paula Sedano Ferreras, David Ruano Domínguez, Carmen González San Segundo, Francisco Díaz Gutiérrez
Publikováno v:
Anales de Pediatría, Vol 95, Iss 6, Pp 473-475 (2021)
Autor:
Alvaro Lassaletta, Pedro Cuesta-Álvaro, Carmen González-San Segundo, Paula Sedano, Carmen Garrido Colino, Marta Perez-Somarriba, Francisco Diaz-Gutiérrez, Lourdes De Ingunza
Publikováno v:
European Journal of Pediatrics. 180:127-136
Medulloblastoma (MB) is a malignant embryonal tumor that develops especially in childhood, with overall survival (OS) at 5 years of up to 70%. The objective of this study is to analyze treatment delivery variables in a retrospective cohort and evalua
Publikováno v:
World Journal of Clinical Oncology
The indication for salvage radiotherapy (RT) (SRT) in patients with biochemically-recurrent prostate cancer after surgery is based on prostate-specific antigen (PSA) levels at the time of biochemical recurrence. Although there are clear criteria (pT3
Publikováno v:
Translational Cancer Research
There are few trials published on treatment in elderly women with low-risk breast cancer. Although the clinical behavior is like younger patients, there is a tendency to undertreat them, which may lead to an increase in the risk of local relapses and